Skip to main content

Reporter Nov 12 2021

AI predicts 24-hour hospital discharge

Nov. 16, 2021—Vanderbilt researchers used a machine learning algorithm and data from more than 26,000 hospital stays to predict who would and would not be discharged over the next 24 hours.

Read more


Who’s who in the respiratory landscape

Nov. 15, 2021—A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples.

Read more


Vaccination day at Children’s Hospital

Nov. 11, 2021—Monroe Carell Jr. Children's Hospital at Vanderbilt began mass vaccination for children ages 5-11 on Monday, Nov. 8.

Read more


CRISPR screen identifies new anti-inflammatory drug target

Nov. 11, 2021—A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.

Read more


The power of white matter

Nov. 11, 2021—Using a novel analysis of fMRI data, Vanderbilt researchers discovered intriguing patterns of signals in the brain’s white matter, the “conduit” for relaying signals between different brain regions.

Read more


VUMC team puts tool to reduce heart failure admissions to test

Nov. 11, 2021—Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

Read more


New way to bEET insulin resistance

Nov. 11, 2021—Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

Read more


International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes

Nov. 11, 2021—  by Jill Clendening Nearly 400 investigators and scientific trainees hailing from 25 different countries recently gathered virtually, across continents and time zones, to share their latest research related to the immunology of Type 1 diabetes during the 18th Immunology of Diabetes Society (IDS) Congress, co-hosted by Vanderbilt University Medical Center and the University of...

Read more


VUMC tests drugs for COVID outpatient treatment

Nov. 11, 2021—  by Paul Govern Vanderbilt University Medical Center has joined a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a...

Read more


Translational Research Forum honors scientific excellence

Nov. 11, 2021—Vanderbilt University Medical Center’s strength in translational research, which helps “translate” scientific discovery into medical practice, was celebrated recently during the Vanderbilt Translational Research Forum

Read more


New awards honor contributions of medical assistants

Nov. 11, 2021—Vanderbilt University Medical Center has announced that Paula Ciero, CCMA and Jo Ann Kounlavong, RMA have received the inaugural Medical Assistant of the Year awards for 2021.

Read more


COVID test accuracy appears to vary by time of day

Nov. 10, 2021—Vanderbilt researchers are examining the effect of time of day on COVID test accuracy.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more